Live Vital NAD+ review

The important number is the three-month total

Live Vital’s NAD+ treatment page is clearer than many monthly headlines: $149 per month is attached to a three-month protocol totaling $447. ^[1] That makes the upfront comparison more meaningful. It is not the same proposition as a one-month order at $149. A reader should assess the full commitment alongside the intended clinical purpose and the uncertainty of benefit. Lowering the allocated monthly cost does not change the evidentiary limits of an elective NAD+ injection program.

A specific route, with individualized prescribing

The page identifies a compounded injectable NAD+ treatment, reviewed after medical intake with dose and schedule set by the clinician. It also describes check-ins and portal messaging. ^[1] Those are useful service details because they tell the buyer what kind of arrangement is being considered. They do not provide a universal dosing schedule or a reason to compare nominal milligrams across routes. Before accepting a plan, request the actual concentration, supplies and instructions that will accompany the pharmacy-dispensed product.

The optional phone conversation is a practical strength

Live Vital offers a free fifteen-minute phone consultation or a direct online intake. Its homepage identifies Dr. Patrick Taylor as the physician leading the medical team and says care is limited to its listed states. ^[2] For someone unsure what the program includes, the call is a useful opportunity to clarify the purpose before committing. A named clinician improves the ability to ask a specific question; it does not independently verify every promotional biography detail or guarantee that the treatment is suitable.

For the clinical distinction, read oral injected infused nad.

The page keeps compounded status visible

The dedicated product page states that the preparation is not FDA-approved and that outcomes vary. ^[1] That direct language is a merit. It helps distinguish the existence of licensed clinical and pharmacy involvement from approval of the finished compounded product. Our assessment is that readers should preserve that distinction when comparing this program with a supplement or an infusion clinic. Supervision and delivery logistics can be compared on their own, while a promised improvement in function still requires evidence for the actual intervention and outcome.

A biochemical role is not a clinical result

Live Vital describes NAD+ as a coenzyme involved in cellular energy metabolism. ^[1] That explanation identifies the molecule, but it cannot establish that adding the prescribed product improves a reader’s energy, cognition or lifespan. An attractive mechanism is not a substitute for an appropriate controlled outcome study. Ask which human trial supports the particular benefit under discussion and whether its route and population match the proposed program. A careful clinician can explain uncertainty without needing to turn a biochemical fact into a guaranteed experience.

Clarify stopping rules before a prepaid protocol

The treatment page directs readers to a refund and cancellation policy. ^[1] We would obtain that policy and the selected agreement before paying, particularly the consequences if treatment is declined, changed or discontinued during the three-month period. The public monthly equivalent alone does not establish a pro-rated refund. Also confirm what support is included throughout the term and how a delayed shipment is handled. That information is especially important for an optional program where a person may reconsider the commitment before all planned supplies arrive.

For a separate service comparison, see CoreAge Rx versus AgelessRx NAD+; compare the actual treatment and terms rather than assuming the services are interchangeable.

A defensible shortlist position

Live Vital deserves consideration for a reader who values a named clinical team, optional preliminary conversation and a visibly stated three-month price. Its limitation is the clinical proposition, not just the bill: the service arrangement does not demonstrate a meaningful rejuvenation outcome. Someone wanting to sample a single month should compare that flexibility explicitly rather than assuming it is available. Our verdict is to assess this as a supervised compounded NAD+ protocol with a $447 commitment, and to keep any expected benefit appropriately bounded.

Understanding the cost

$149/month is a $447 total three-month NAD+ protocol, not a verified single-month purchase. Confirm payment timing and discontinuation terms. ^[1]